image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Filing Date
February 08, 2021
Document Date
February 08, 2021
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC